Platelet concentration in platelet-rich plasma affects tenocyte behavior in vitro

Area of Science:

• Orthopedics
• Regenerative Medicine
• Biomaterials Science

Background:

• Tendon injuries and tendinopathy present a significant clinical challenge, often necessitating surgical intervention.
• Platelet-rich plasma (PRP) is a promising therapeutic agent due to its high concentration of growth factors essential for tissue repair.
• Optimizing PRP composition, specifically platelet concentration, is vital for enhancing conservative tendon healing strategies.

Purpose of the Study:

• To investigate the impact of varying platelet concentrations in PRP on the biological behavior of human tenocytes.
• To determine the optimal platelet concentration for promoting key cellular processes involved in tendon healing.

Main Methods:

• In vitro study utilizing normal human tenocytes.
• Exposure of tenocytes to a range of platelet concentrations (up to 5 × 10^6 plt/µL).
• Assessment of tenocyte proliferation, migration, collagen production, and matrix metalloproteinase (MMP) production.

Main Results:

• Intermediate platelet concentrations (0.5-1 × 10^6 plt/µL) significantly stimulated tenocyte proliferation, migration, collagen, and MMP production.
• The highest tested platelet concentration exhibited inhibitory effects on proliferation and migration, alongside reduced collagen synthesis.
• High platelet concentrations paradoxically increased MMP production, potentially compromising tendon mechanical stability.

Conclusions:

• The efficacy of PRP in tendon healing is concentration-dependent.
• A balanced, intermediate concentration of platelets in PRP is optimal for promoting tenocyte proliferation, migration, and collagen synthesis.
• Excessively high platelet concentrations may impede tendon healing due to reduced cellular activity and increased matrix degradation.